Prevalence and Clinical Implications of HPV Infection in Male IBD Patients
NCT05911750 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 384
Last updated 2025-09-12
Summary
The study aims at describing the prevalence of Human Papillomavirus (HPV) infection in anal and oral samples of men with Inflammatory Bowel Disease (IBD) and detecting risk factors for the infection.
Conditions
- HPV Infection
- Dysplasia Anus
- Oral Cavity Disease
Interventions
- DIAGNOSTIC_TEST
-
Anal pap smear and oral swab for cytology and HPV testing
Anal and oral swab sampling for HPV detection (polymerase chain reaction) and cytology
Sponsors & Collaborators
-
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
lead OTHER
Principal Investigators
-
Antonio Giordano, MD · [email protected]
Eligibility
- Min Age
- 18 Years
- Max Age
- 79 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-12
- Primary Completion
- 2026-01-31
- Completion
- 2026-06-01
Countries
- Spain
Study Locations
More Related Trials
-
Asymptomatic Inflammatory Bowel Disease in Catalonia
NCT04794465 ·Status: UNKNOWN
-
Investigation of Sexual Function in Crohn's Disease Patients With Perianal Fistulas
NCT01635543 ·Status: WITHDRAWN
-
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
NCT06456593 ·Status: RECRUITING ·Phase: PHASE2
-
OPTImization of Inflammatory Bowel Disease Treatment Through Understanding of Gut VIRome Heterogeneity
NCT07240181 ·Status: NOT_YET_RECRUITING
-
Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
NCT05598489 ·Status: UNKNOWN
-
Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy
NCT07089771 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study
NCT05452187 ·Status: COMPLETED
-
Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease
NCT04151225 ·Status: WITHDRAWN ·Phase: PHASE2
-
Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal
NCT04997733 ·Status: RECRUITING ·Phase: PHASE3
-
Endomicroscopy in IBD Patients
NCT01417728 ·Status: COMPLETED
-
A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis
NCT03844932 ·Status: TERMINATED ·Phase: PHASE2
-
Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)
NCT05817942 ·Status: ACTIVE_NOT_RECRUITING
-
Prevalence of Helicobacter Pylori on Patients With Chronic Inflammatory Bowel Disease (IBD) at the CHU of Guadeloupe
NCT07292454 ·Status: NOT_YET_RECRUITING
-
Evaluation of a Multimodal Day Hospital for the Overall Management of Patients With Chronic Inflammatory Bowel Diseases (IBD)
NCT07167186 ·Status: NOT_YET_RECRUITING
-
TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
NCT06051253 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease
NCT03992469 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study of the 12-month Efficacy of Stem Cell Injection in Crohn's Disease With Complex Ano-perineal Fistula
NCT05177003 ·Status: UNKNOWN
-
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
NCT01277666 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease
NCT01751152 ·Status: COMPLETED ·Phase: PHASE2
-
Lipid Mediators in Colonic Biopsies as Biomarkers of Disease Activity of Inflammatory Bowel Diseases
NCT01990716 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of HMPL-004 in Subjects With Crohn's Disease
NCT00655733 ·Status: COMPLETED ·Phase: PHASE2
-
The Comparison Between the Biomarkers in Inflammatory Bowel Disease Patients and General Control Group
NCT03778918 ·Status: UNKNOWN
-
Impact of the Fecal Flora Transplantation on Crohn's Disease
NCT02097797 ·Status: COMPLETED ·Phase: NA
-
A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease
NCT02904590 ·Status: COMPLETED